Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Incyte Corp (INCY)

Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,595,016
  • Shares Outstanding, K 192,650
  • Annual Sales, $ 3,696 M
  • Annual Income, $ 597,600 K
  • EBIT $ -53 M
  • EBITDA $ 30 M
  • 60-Month Beta 0.71
  • Price/Sales 4.03
  • Price/Cash Flow 31.74
  • Price/Book 4.69

Options Overview Details

View History
  • Implied Volatility 48.35% ( +1.15%)
  • Historical Volatility 38.13%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 48.35% on 11/07/24
  • IV Low 18.10% on 05/16/24
  • Put/Call Vol Ratio 0.14
  • Today's Volume 4,068
  • Volume Avg (30-Day) 1,606
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 36,413
  • Open Int (30-Day) 23,306

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.26
  • Number of Estimates 9
  • High Estimate 1.69
  • Low Estimate 0.42
  • Prior Year 0.82
  • Growth Rate Est. (year over year) +53.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.59 +27.48%
on 10/10/24
82.97 -0.76%
on 11/07/24
+16.58 (+25.21%)
since 10/07/24
3-Month
60.19 +36.79%
on 08/08/24
82.97 -0.76%
on 11/07/24
+22.05 (+36.57%)
since 08/07/24
52-Week
50.35 +63.54%
on 04/30/24
82.97 -0.76%
on 11/07/24
+27.62 (+50.48%)
since 11/07/23

Most Recent Stories

More News
Incyte: Q3 Earnings Snapshot

Incyte: Q3 Earnings Snapshot

INCY : 82.34 (+1.72%)
What to Expect From Incyte's Next Quarterly Earnings Report

Incyte will release its third-quarter earnings later this month, and analysts anticipate a double-digit profit growth.

XLV : 149.11 (+0.72%)
$SPX : 5,973.10 (+0.74%)
INCY : 82.34 (+1.72%)
Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico

GUD.TO : 5.15 (-10.28%)
INCY : 82.34 (+1.72%)
Is Incyte Stock Underperforming the Nasdaq?

Despite Incyte’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

$NASX : 19,269.46 (+1.51%)
INCY : 82.34 (+1.72%)
EXEL : 35.80 (+0.82%)
Incyte Gains 12.7% Year to Date: How Should You Play the Stock?

Shares of Incyte INCY have risen 12.7% in the past six months against the industry’s decline of 0.5%. The stock has also outperformed the sector and the S&P 500 during this time frame.The outperformance...

INCY : 82.34 (+1.72%)
NVS : 107.08 (+0.25%)
GSK : 36.66 (+2.12%)
Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase

/CNW/ -- USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on...

ONCY : 1.0700 (-4.46%)
FHTX : 9.11 (-1.41%)
NRIX : 27.24 (+0.89%)
INCY : 82.34 (+1.72%)
ONC.TO : 1.50 (-3.23%)
REGN : 824.48 (+0.96%)
S&P 500 Falls from a Record High on Hawkish Powell

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down by -0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.45%....

$SPX : 5,973.10 (+0.74%)
SPY : 595.61 (+0.77%)
$DOWI : 43,729.34 (unch)
DIA : 437.39 (+0.04%)
$IUXX : 21,101.57 (+1.54%)
QQQ : 513.54 (+1.57%)
ZNZ24 : 110-150 (+0.26%)
INTC : 26.23 (+4.71%)
NVDA : 148.88 (+2.25%)
AMD : 149.82 (+3.25%)
MRVL : 93.94 (+3.65%)
MU : 113.41 (+1.41%)
Stocks Jolted By Fed's 50-Basis Point Rate Cut

The S&P 500 Index ($SPX ) (SPY ) today is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.25%. Stocks today have erased knee-jerk...

$SPX : 5,973.10 (+0.74%)
SPY : 595.61 (+0.77%)
$DOWI : 43,729.34 (unch)
DIA : 437.39 (+0.04%)
$IUXX : 21,101.57 (+1.54%)
QQQ : 513.54 (+1.57%)
ZNZ24 : 110-150 (+0.26%)
SMCI : 25.48 (+12.25%)
VFC : 21.63 (+3.89%)
VSCO : 35.85 (+8.24%)
GEHC : 88.33 (+1.79%)
X : 41.99 (-0.76%)
Stocks Slightly Higher Before FOMC Decision

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.11%. Stocks today are slightly...

$SPX : 5,973.10 (+0.74%)
SPY : 595.61 (+0.77%)
$DOWI : 43,729.34 (unch)
DIA : 437.39 (+0.04%)
$IUXX : 21,101.57 (+1.54%)
QQQ : 513.54 (+1.57%)
ZNZ24 : 110-150 (+0.26%)
SMCI : 25.48 (+12.25%)
CCL : 23.68 (-2.27%)
NCLH : 27.05 (-2.56%)
RCL : 220.52 (-2.70%)
VFC : 21.63 (+3.89%)
Tech Stocks Close Lower on Weakness in Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.47%. Stocks...

$SPX : 5,973.10 (+0.74%)
SPY : 595.61 (+0.77%)
$DOWI : 43,729.34 (unch)
DIA : 437.39 (+0.04%)
$IUXX : 21,101.57 (+1.54%)
QQQ : 513.54 (+1.57%)
ZNZ24 : 110-150 (+0.26%)
AAPL : 227.48 (+2.14%)
QRVO : 72.06 (-1.10%)
SWKS : 91.17 (+0.77%)
ARM : 150.65 (+4.13%)
MU : 113.41 (+1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2...

See More

Key Turning Points

3rd Resistance Point 87.14
2nd Resistance Point 85.05
1st Resistance Point 83.70
Last Price 82.34
1st Support Level 80.26
2nd Support Level 78.17
3rd Support Level 76.82

See More

52-Week High 82.97
Last Price 82.34
Fibonacci 61.8% 70.51
Fibonacci 50% 66.66
Fibonacci 38.2% 62.81
52-Week Low 50.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar